Breaking News

PTI Appoints Tech Transfer Director

April 8, 2014

Cox to oversee commercialization activities for the transfer of technology

Bryan Cox has been promoted to director of Technology Transfer at Pharma Tech Industries (PTI). Mr. Cox will oversee all commercialization activities for the transfer of technology and integration of new customers at all of the company’s manufacturing sites. Mr. Cox previously served as plant manager of the company’s primary facility in Royston, GA. He joined the company in October 2010 as a staff engineer.
The company recently expanded its on-site testing capabilities at its Royston plant with a new analytical lab for both Rx and OTC drugs. The company is also expanding its production facility in Union, MO, with approximately 60,000 sq.-ft. of additional manufacturing space, which will be used primarily for the production of ingestible powders and will include a production room built to ISO8/100,000 clean room standards. The project is scheduled to be completed in 4Q14.
“During his tenure with Pharma Tech Industries, Byran has consistently demonstrated success managing a diverse roster of projects effectively,” said Tee Noland, chairman of Pharma Tech Industries.  “As PTI continues to add new services and take on new customers, Bryan will play an instrumental role in leading the technological transfer process to ensure flawless execution during the hand off between sales and commercial production.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks